H. pylori Outer Membrane Protein Antibody Response, MHC/HLA-DMA Methylation, and Gastric Cancer Risk: A Multi-Layer Evidence Integration Study Using Mendelian Randomization
Genes · 2026
DOI: 10.3390/genes17091125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Yangxi Fu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Helicobacter pylori, DNA Methylation, Helicobacter Infections. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Xiyuan Hospital.
Abstract (Originalsprache)
Background
Helicobacter pylori (H. pylori) infection is a well-established risk factor for gastric cancer; however, evidence on the associations between antigen-specific antibody traits, host methylation, and gastric cancer risk remains limited.
Methods
Using a forward two-sample Mendelian randomization (MR) design, we integrated methylation quantitative trait loci (mQTLs), external cohorts, The Cancer Genome Atlas–Stomach Adenocarcinoma (TCGA-STAD), and functional annotations through a three-stage framework (antibody trait screening, CpG prioritization, and external replication) to evaluate a two-step pathway from host antibody response to gastric cancer via DNA methylation.
Results
Among six H. pylori antigens, antibody response to outer membrane protein (OMP) showed the strongest positive association with gastric cancer risk (OR = 1.186, 95% CI: 1.079–1.304, raw p = 4.08 × 10−4). CpG-level prioritization identified cg24290947 (annotated to HLA-DMA) as a methylation site linked to gastric cancer susceptibility, with an inverse MR association (beta = −0.2347, 95% CI: −0.3980 to −0.0713, raw p = 0.00487). External exploration showed that cg24290947 methylation was elevated in H. pylori-positive gastric mucosa; however, its direct tumor–normal difference in a 12-pair cohort was not significant, although regional methylation perturbations were observed. HLA-DMA and MHC-II expression were consistently higher in tumor versus normal tissues across three cohorts, whereas TCGA-STAD did not support a stable linear relationship between cg24290947 methylation and HLA-DMA/MHC-II expression; three of six composition-adjusted models showed nominal significance but were model-dependent. These signals were enriched in antigen processing and presentation pathways. Conclusions: cg24290947/HLA-DMA represents a hypothesis-generating regional methylation candidate for further investigation rather than a confirmed linear transcriptional regulator. The MR evidence is based on European-ancestry summary data; its generalizability and any clinical predictive value warrant independent evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China.
- Institute of Digestive Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China.
- Beijing Traditional Chinese Medicine Research Institute Co., Ltd., Beijing 100011, China.
Förderung
- National Natural Science Foundation of China
- Xiyuan Hospital
Zitieren
APA
Fu, Y., Wang, Z., Liu, S., Liu, L., & Tang, X. (2026). H. pylori Outer Membrane Protein Antibody Response, MHC/HLA-DMA Methylation, and Gastric Cancer Risk: A Multi-Layer Evidence Integration Study Using Mendelian Randomization. Genes. https://doi.org/10.3390/genes17091125
Vancouver
Fu Y, Wang Z, Liu S, Liu L, Tang X. H. pylori Outer Membrane Protein Antibody Response, MHC/HLA-DMA Methylation, and Gastric Cancer Risk: A Multi-Layer Evidence Integration Study Using Mendelian Randomization. Genes. 2026. doi:10.3390/genes17091125
BibTeX
@article{Fu2026,
author = {Fu, Yangxi and Wang, Zheng and Liu, Shan and Liu, Lin and Tang, Xudong},
title = {H. pylori Outer Membrane Protein Antibody Response, MHC/HLA-DMA Methylation, and Gastric Cancer Risk: A Multi-Layer Evidence Integration Study Using Mendelian Randomization},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17091125}
}
EUVIMED